Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura

Clin Lab Haematol. 2006 Aug;28(4):288-9. doi: 10.1111/j.1365-2257.2006.00794.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Female
  • Humans
  • Immunologic Factors / administration & dosage*
  • Purpura, Thrombotic Thrombocytopenic / drug therapy*
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunologic Factors
  • Rituximab